| Literature DB >> 33860110 |
Akihisa Watanabe1, Qana Ono-Matsukubo1, Tomohiko Nishigami2, Toshiki Maitani3, Akira Mibu4, Takahiko Hirooka5, Hirohisa Machida1.
Abstract
OBJECTIVES: Subacromial pain syndrome is a common problem in primary care. Although several randomized controlled trials have shown that eccentric exercise is effective in patients with subacromial pain syndrome, its generalizability to real-world clinical practice is unknown. This study aimed to investigate, using propensity score analysis, the generalizability of eccentric exercise for patients with subacromial pain syndrome to real-world daily clinical practice.Entities:
Keywords: daily clinical practice; eccentric exercise; pain control; propensity score analysis; subacromial pain syndrome
Year: 2021 PMID: 33860110 PMCID: PMC8041652 DOI: 10.2490/prm.20210019
Source DB: PubMed Journal: Prog Rehabil Med ISSN: 2432-1354
Treatment undergone by the Ecc(+) group and Ecc(−) group
| Treatment | |
| Common to the Ecc(+) group and Ecc(−) group | Medication |
| Ecc(+) group only | Two eccentric exercises |
Ecc(+), eccentric exercises group; Ecc(−), no-eccentric exercises group.
Patient characteristics before and after propensity score matching analysis
| Unadjusted | PSM | |||||
| Ecc(+) | Ecc(–) | Standardized difference | Ecc(+) | Ecc(–) | Standardized difference | |
| Age, years (SD) | 57.8 (17.7) | 58.0 (11.8) | 0.014 | 57.3 (17.9) | 57.7 (11.3) | 0.027 |
| Sex, female (%) | 38 (49.4%) | 44 (53.8%) | 0.142 | 34 (52.3%) | 33 (50.8%) | 0.031 |
| Affected side, | 29 (37.7%) | 42 (53.8%) | 0.329 | 28 (43.1%) | 30 (46.2%) | 0.089 |
| Duration, months (SD) | 4.3 (5.7) | 5.8 (8.2) | 0.203 | 4.6 (6.1) | 5.1 (6.6) | 0.070 |
| VAS-rest (SD) | 29.2 (28.0) | 31.0 (23.4) | 0.071 | 29.4 (27.9) | 28.6 (21.4) | 0.032 |
| VAS-activity (SD) | 52.3 (26.8) | 59.8 (18.5) | 0.325 | 55.1 (25.4) | 57.1 (17.9) | 0.090 |
| VAS-night (SD) | 37.4 (28.6) | 39.9 (25.3) | 0.092 | 36.8 (28.1) | 37.1 (24.1) | 0.012 |
| ASES (SD) | 48.6 (15.2) | 46.5 (17.2) | 0.127 | 48.0 (14.6) | 47.2 (17.1) | 0.050 |
| SIS, n (%) | 39 (50.6%) | 45 (57.7%) | 0.142 | 33 (50.8%) | 34 (52.3) | 0.031 |
Data are presented as the mean (SD) for continuous variables and as a number, (proportion, %) for categorical variables.
PSM, propensity score matching model; VAS, visual analog scale; ASES, American Shoulder and Elbow Surgeons Society Standardized Shoulder Assessment Form; SIS, subacromial impingement syndrome.
Patient characteristics weighted using inverse probability of treatment analysis
| IPTW | |||
| Ecc(+) | Ecc(–) | Standardized difference | |
| Age, years (SD) | 57.7 (17.3) | 57.4 (11.8) | 0.021 |
| Sex, female (%) | 81.2 (52.1%) | 81.6 (53.4%) | 0.025 |
| Affected side, right (%) | 71.0 (45.6%) | 70.6 (46.2%) | 0.012 |
| Duration, months (SD) | 4.7 (6.2) | 5.0 (7.1) | 0.052 |
| VAS-rest (SD) | 27.9 (28.0) | 28.9 (22.1) | 0.041 |
| VAS-activity (SD) | 56.9 (26.1) | 57.4 (18.1) | 0.025 |
| VAS-night (SD) | 37.1 (28.2) | 37.9 (24.7) | 0.030 |
| ASES (SD) | 47.4 (14.7) | 47.1 (17.0) | 0.018 |
| SIS, N (%) | 86.9 (55.8%) | 84.0 (54.9%) | 0.017 |
Data are presented as the mean (SD) for continuous variables, as a number, (proportion, %) for categorical variables.
IPTW, weighting by inverse probability of treatment model.
Effect of exercise on VAS-activity with and without propensity score matching
| Baseline | After treatment | Difference before and | Difference between the two groups (95% CI) | ||
| Unadjusted | Ecc(+), n=77 | 52.3 (26.8) | 28.5 (19.8) | –23.8 (–31.3 to –16.3), P<0.001 | –14.7 (–21.2 to –8.3) |
| Ecc(–), n=78 | 59.8 (18.5) | 43.8 (21.3) | –16.0 (–22.8 to –10.3), P<0.001 | P<0.001 | |
| PSM | Ecc(+), n=65 | 55.1 (25.4) | 26.7(17.1) | –28.4 (–36.0 to –21.0), P<0.001 | –14.5 (–21.2 to –7.9) |
| Ecc(–), n=65 | 57.1 (17.9) | 41.2 (20.7) | –15.9 (–22.6 to –9.2), P<0.001 | P<0.001 |
Data represent mean (SD).
CI, confidence interval.
Changes in VAS-activity and ASES weighted by inverse probability of treatment analysis
| Baseline | After treatment | Difference before and | Difference between the two groups (95% CI) | ||
| VAS-activity | Ecc(+) | 56.9 (26.1) | 29.2 (19.5) | –27.7 (–31.8 to –23.6), P<0.001 | –14.4 (–20.8 to –8.0) |
| Ecc(–) | 57.4 (18.1) | 43.6 (20.5) | –13.8 (–17.1 to –10.5), P<0.001 | P<0.001 | |
| ASES | Ecc(+) | 47.4 (14.7) | 57.2 (18.1) | 9.8 (7.3 to 12.3), P<0.001 | 0.2 (–5.6 to 6.0) |
| Ecc(–) | 47.1 (17.0) | 57.0 (17.6) | 9.9 (7.1 to 12.6), P<0.001 | P=0.95 |
Data represent mean (SD).
Effect of exercise on ASES with and without propensity score matching
| Baseline | After treatment | Difference before and | Difference between the two groups (95% CI) | ||
| Unadjusted | Ecc(+), n=77 | 48.6 (15.2) | 59.0 (18.3) | 10.4 (5.1 to 15.8), P<0.001 | 3.4 (–2.1 to 8.9) |
| Ecc(–), n=78 | 46.5 (17.2) | 55.6 (17.8) | 9.1 (4.1 to 15.1), P=0.001 | P=0.30 | |
| PSM | Ecc(+), n=65 | 48.0 (14.6) | 60.4 (17.4) | 12.4 (6.9 to 18.0), P<0.001 | 4.1 (–2.0 to 10.2) |
| Ecc(–), n=65 | 47.2 (17.1) | 56.3 (17.6) | 9.1 (3.1 to 15.1), P<0.001 | P=0.18 |
Data represent mean (SD).
Propensity score matching analysis of VAS-activity changes in SIS(+) and SIS(–) subgroups
| Baseline | After treatment | Difference before and after (95% CI) | Difference between Ecc(+) and Ecc(–) (95% CI) | |
| SIS(+) (n=67) | ||||
| Ecc(+), n=33 | 54.1 (27.9) | 20.9 (13.9) | –33.2 (–44.6 to –22.0), P<0.001 | –18.0 (–27.6 to –9.2), P<0.001 |
| Ecc(–), n=34 | 60.9 (18.2) | 38.9 (21.9) | –22.0 (–38.9 to –12.1), P<0.001 | |
| SIS(–) (n=63) | ||||
| Ecc(+), n=32 | 56.2 (22.9) | 32.6 (18.2) | –24.6 (–33.6 to –12.3), P<0.001 | –11.0 (–20.8 to –1.2), P=0.02 |
| Ecc(–), n=31 | 53.0 (16.8) | 43.6 (19.3) | –9.4 (–19.5 to –0.8), P=0.03 |
Data represent mean (SD).